ELI LILLY AND COMPANY Income Taxes Paid
ELI LILLY AND COMPANY (LLY) reported Income Taxes Paid of $6.56 billion for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2025-02-19
- ELI LILLY AND COMPANY income taxes paid for the quarter ending 2016-12-31 was $536.40M.
- ELI LILLY AND COMPANY income taxes paid for the quarter ending 2016-09-30 was $0.00.
- ELI LILLY AND COMPANY income taxes paid for the quarter ending 2016-06-30 was $20.00M.
- ELI LILLY AND COMPANY income taxes paid for the quarter ending 2016-03-31 was $130.00M.
- ELI LILLY AND COMPANY income taxes paid for fiscal 2024 was $6.56B, a 18.05% increase from fiscal 2023.
- ELI LILLY AND COMPANY income taxes paid for fiscal 2023 was $5.56B, a 107.97% increase from fiscal 2022.
- ELI LILLY AND COMPANY income taxes paid for fiscal 2022 was $2.67B, a 67.18% increase from fiscal 2021.
- ELI LILLY AND COMPANY income taxes paid for fiscal 2021 was $1.60B, a 67.48% increase from fiscal 2020.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 3 month as first filed | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $6.56B 10-K · filed 2025-02-19 | |||||
| 2023-12-31 | $5.56B 10-K · filed 2025-02-19 | |||||
| 2022-12-31 | $2.67B 10-K · filed 2025-02-19 | |||||
| 2021-12-31 | $1.60B 10-K · filed 2024-02-21 | |||||
| 2020-12-31 | $954.60M 10-K · filed 2023-02-22 | |||||
| 2019-12-31 | $1.18B 10-K · filed 2022-02-23 | |||||
| 2018-12-31 | $1.08B 10-K · filed 2021-02-17 | $1.10B 10-K · filed 2019-02-19 | ||||
| 2017-12-31 | $221.50M 10-K · filed 2020-02-19 | $246.50M 10-K · filed 2018-02-20 | ||||
| 2016-12-31 | $536.40M derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24 | $536.40M derived: sum of 2 quarters · filed 2019-10-24 | $556.40M derived: sum of 3 quarters · filed 2019-10-24 | $686.40M 8-K · filed 2019-10-24 | $700.60M 10-K · filed 2017-02-21 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $20.00M derived: sum of 2 quarters · filed 2016-10-28 | $150.00M 10-Q · filed 2016-10-28 | |||
| 2016-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $150.00M 10-Q · filed 2016-07-28 | ||||
| 2016-03-31 | $130.00M 10-Q · filed 2016-04-29 | |||||
| 2015-12-31 | $969.00M 10-K · filed 2018-02-20 | |||||
| 2014-12-31 | $729.70M 10-K · filed 2017-02-21 | |||||
| 2013-12-31 | $1.26B 10-K · filed 2016-02-19 | $1.26B 10-K · filed 2014-02-19 | ||||
| 2012-12-31 | $992.00M 10-K · filed 2015-02-19 | |||||
| 2011-12-31 | $942.80M 10-K · filed 2014-02-19 | $943.00M 10-K · filed 2012-02-24 | ||||
| 2011-09-30 | $120.00M 10-Q · filed 2011-10-28 | $40.00M 10-Q · filed 2011-07-29 | $180.00M 10-Q · filed 2011-10-28 | |||
| 2011-06-30 | $140.00M 10-Q · filed 2011-07-29 | |||||
| 2010-12-31 | $861.00M 10-K · filed 2013-02-21 | |||||
| 2009-12-31 | $1.14B 10-K · filed 2012-02-24 | |||||
| 2009-09-30 | $52.80M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |